Objective:To observe the effects of ZI QIAN compound on the treatment of chronic immune thrombocytopenia (CITP) through the changes of the total symptom score,PLT count and peripheral blood death factor ligand Fasl. To discuss the mechanism of CITP and the effect of ZI QIAN compound to CITP and provide the theoretical basis for the further clinical application of ZI QIAN compound.
Methods:30 patients with CITP were treated with the ZI QIAN compound for two courses which contain two months, Evaluate the ...